189 related articles for article (PubMed ID: 38384464)
1. Spinal HMGB1 participates in the early stages of paclitaxel-induced neuropathic pain via microglial TLR4 and RAGE activation.
Moraes TR; Veras FP; Barchuk AR; Nogueira ESC; Kanashiro A; Galdino G
Front Immunol; 2024; 15():1303937. PubMed ID: 38384464
[TBL] [Abstract][Full Text] [Related]
2. Identification of a functional interaction of HMGB1 with Receptor for Advanced Glycation End-products in a model of neuropathic pain.
Allette YM; Due MR; Wilson SM; Feldman P; Ripsch MS; Khanna R; White FA
Brain Behav Immun; 2014 Nov; 42():169-77. PubMed ID: 25014009
[TBL] [Abstract][Full Text] [Related]
3. Evidence of a role for spinal HMGB1 in ischemic stress-induced mechanical allodynia in mice.
Matsuura W; Harada S; Liu K; Nishibori M; Tokuyama S
Brain Res; 2018 May; 1687():1-10. PubMed ID: 29476751
[TBL] [Abstract][Full Text] [Related]
4. Involvement of high mobility group box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats.
Nishida T; Tsubota M; Kawaishi Y; Yamanishi H; Kamitani N; Sekiguchi F; Ishikura H; Liu K; Nishibori M; Kawabata A
Toxicology; 2016 Jul; 365():48-58. PubMed ID: 27474498
[TBL] [Abstract][Full Text] [Related]
5. Spinal high-mobility group box-1 induces long-lasting mechanical hypersensitivity through the toll-like receptor 4 and upregulation of interleukin-1β in activated astrocytes.
Morioka N; Miyauchi K; Miyashita K; Kochi T; Zhang FF; Nakamura Y; Liu K; Wake H; Hisaoka-Nakashima K; Nishibori M; Nakata Y
J Neurochem; 2019 Sep; 150(6):738-758. PubMed ID: 31273787
[TBL] [Abstract][Full Text] [Related]
6. Glycyrrhizin ameliorates inflammatory pain by inhibiting microglial activation-mediated inflammatory response via blockage of the HMGB1-TLR4-NF-kB pathway.
Sun X; Zeng H; Wang Q; Yu Q; Wu J; Feng Y; Deng P; Zhang H
Exp Cell Res; 2018 Aug; 369(1):112-119. PubMed ID: 29763588
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA Attenuates Chronic Pancreatitis-Induced Pain in Rats via Downregulation of HMGB1 and TRL4 Expression in the Spinal Cord.
Wang YS; Li YY; Wang LH; Kang Y; Zhang J; Liu ZQ; Wang K; Kaye AD; Chen L
Pain Physician; 2015; 18(4):E615-28. PubMed ID: 26218952
[TBL] [Abstract][Full Text] [Related]
8. Targeting HMGB1-TLR4 signaling by miR-216a-5p elevation alleviates the inflammatory behavioral hypersensitivity.
Zhenzhen Z; Fenghao L; Meina M; Rui L; Wenbo S; Qi W
Neurosci Lett; 2021 Aug; 759():136043. PubMed ID: 34118309
[TBL] [Abstract][Full Text] [Related]
9. Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis.
Agalave NM; Larsson M; Abdelmoaty S; Su J; Baharpoor A; Lundbäck P; Palmblad K; Andersson U; Harris H; Svensson CI
Pain; 2014 Sep; 155(9):1802-1813. PubMed ID: 24954167
[TBL] [Abstract][Full Text] [Related]
10. Anti-nociceptive effects of Sedum Lineare Thunb. on spared nerve injury-induced neuropathic pain by inhibiting TLR4/NF-κB signaling in the spinal cord in rats.
Wang XY; Ma HJ; Xue M; Sun YL; Ren A; Li MQ; Huang ZH; Huang C
Biomed Pharmacother; 2021 Mar; 135():111215. PubMed ID: 33418303
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal lentivirus-mediated transfer of interleukin-10 attenuates chronic constriction injury-induced neuropathic pain through modulation of spinal high-mobility group box 1 in rats.
He Z; Guo Q; Xiao M; He C; Zou W
Pain Physician; 2013; 16(5):E615-25. PubMed ID: 24077211
[TBL] [Abstract][Full Text] [Related]
12. Chronic morphine-mediated upregulation of high mobility group box 1 in the spinal cord contributes to analgesic tolerance and hyperalgesia in rats.
Qian J; Zhu Y; Bai L; Gao Y; Jiang M; Xing F; Zhang J; Zhao W; Gu H; Mi Y; Tao YX; Xu JT
Neurotherapeutics; 2020 Apr; 17(2):722-742. PubMed ID: 31879851
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages/microglia polarization and affords neuroprotection after spinal cord injury.
Fan H; Tang HB; Chen Z; Wang HQ; Zhang L; Jiang Y; Li T; Yang CF; Wang XY; Li X; Wu SX; Zhang GL
J Neuroinflammation; 2020 Oct; 17(1):295. PubMed ID: 33036632
[TBL] [Abstract][Full Text] [Related]
14. Participation of CXCL1 in the glial cells during neuropathic pain.
Moraes TR; Elisei LS; Malta IH; Galdino G
Eur J Pharmacol; 2020 May; 875():173039. PubMed ID: 32119843
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine Alleviates CCI-Induced Neuropathic Pain via Inhibiting HMGB1-Mediated Astrocyte Activation and the TLR4/NF-κB Signaling Pathway in Rats.
Zhao E; Bai L; Li S; Li L; Dou Z; Huang Y; Li Y; Lv Y
Neurotox Res; 2020 Oct; 38(3):723-732. PubMed ID: 32607919
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury.
Chen X; Wu S; Chen C; Xie B; Fang Z; Hu W; Chen J; Fu H; He H
J Neuroinflammation; 2017 Jul; 14(1):143. PubMed ID: 28738820
[TBL] [Abstract][Full Text] [Related]
17. High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.
Han SY; Choi SH; Shin JS; Lee EJ; Han SH; Yoon JS
Thyroid; 2019 Jun; 29(6):868-878. PubMed ID: 30973094
[No Abstract] [Full Text] [Related]
18. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.
Mazarati A; Maroso M; Iori V; Vezzani A; Carli M
Exp Neurol; 2011 Dec; 232(2):143-8. PubMed ID: 21884699
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2/MyD88/NF-κB signaling pathway in spinal microglia.
Yang H; Wu L; Deng H; Chen Y; Zhou H; Liu M; Wang S; Zheng L; Zhu L; Lv X
J Neuroinflammation; 2020 May; 17(1):154. PubMed ID: 32393298
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation.
Dos Santos R; Veras F; Netto G; Elisei L; Sorgi C; Faccioli L; Galdino G
J Pharm Pharmacol; 2023 Apr; 75(5):655-665. PubMed ID: 36946366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
